Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial (Q46689599)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

title

Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

main subject

lymphocyte

0 references

phase II clinical trial

0 references

patient

0 references

leukemia

1 reference

based on heuristic

inferred from title

B-cell chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author

Michael Hallek

series ordinal

16

object named as

Michael Hallek

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

author name string

Thomas Elter

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Peter Borchmann

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Holger Schulz

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Marcel Reiser

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Sven Trelle

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Roland Schnell

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Markus Jensen

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Peter Staib

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Timo Schinköthe

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Hartmut Stützer

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Jürgen Rech

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Martin Gramatzki

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Walter Aulitzky

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Ibrahim Hasan

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Andreas Josting

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Andreas Engert

series ordinal

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

language of work or name

English

0 references

publication date

6 September 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

issue

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

page(s)

7024-7031

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

Identifiers

DOI

10.1200/JCO.2005.01.9950

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

PubMed publication ID

16145065

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16145065

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16145065

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46689599&oldid=2126849670"